RMD ResMed Inc.

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

  • Location:
  • Date:
Thursday, October 24, 2024
  • Time:
1:30 p.m. PDT / 4:30 p.m. EDT
  • International:
London, Thursday, October 24, 2024, 9:30 p.m. BST

Sydney, Friday, October 25, 2024, 7:30 a.m. AEDT



Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from October 24, 2024, until November 7, 2024, at:

  • U.S.: +1 877.660.6853
  • International: +1 201.612.7415
  • Conference ID: 13749420

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit and follow @ResMed.

For investorsFor media
+1 858.836.5000+1 619.510.1281


EN
03/10/2024

Underlying

RMDResMed Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ResMed Inc.

 PRESS RELEASE
Free
RMD RESMED INC.

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 202...

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024 SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: Date: Thursday, October 24, 2024 Ti...

October 3, 2024 1 EN
Free Trial
RMD RESMED INC.

ResMed Inc: 1 director

A director at ResMed Inc sold 2,000 shares at 237.200USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

10/03/24 October 3, 2024 1 EN
 PRESS RELEASE
Free
RMD RESMED INC.

ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Share...

ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns 2030 ambition to help more than 500 million people worldwide achieve their full health potentialShowcases integration of intelligent products and solutions within the ResMed ecosystem, designed to deliver a better experience, lower costs, and enhanced outcomes for patients and providersIntroduces updated five-year financial outlook NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and shareholder ...

September 30, 2024 1 EN
 PRESS RELEASE
Free
RMD RESMED INC.

UPDATE -- ResMed Unveils New Collection of Digital and Personalized So...

UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir™ consumer app with Apple and Android smartwatches. Introduces a Generative AI-enabled sleep health assistant to guide people on their journey to better sleep and new travel gear to help people stay on CPAP treatment while traveling. SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- (NYSE: RMD, ASX: RMD), the world’s leadin...

September 30, 2024 1 EN
 PRESS RELEASE
Free
RMD RESMED INC.

UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Des...

UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ResMed first in CPAP (continuous positive airway pressure) mask innovation with ...

September 30, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch